Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread-Reference-Cited by-同舟云学术

Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread

Published:2021-11 Issue: Volume:223 Page:113601
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Garcia Manon,Hoffer Laurent,Leblanc Raphaël,Benmansour Fatiha,Feracci Mikael,Derviaux Carine,Egea-Jimenez Antonio Luis,Roche Philippe,Zimmermann Pascale,Morelli Xavier,Barral Karine

Funder

Agence nationale de la recherche

European Commission

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. Exosomes and their roles in immune regulation and cancer;Greening;Semin. Cell Dev. Biol.,2015

2. Exosome-mediated metastasis: communication from a distance;Wortzel;Dev. Cell,2019

3. The origin and functions of exosomes in cancer;Rajagopal;Front Oncol,2018

4. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains;Grootjans;Proc. Natl. Acad. Sci. U. S. A.,1997

5. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish;Lambaerts;J. Cell Sci.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ChemoDOTS: a web server to design chemistry-driven focused libraries;Nucleic Acids Research;2024-04-30

2. WITHDRAWN: Discovery of a potent inhibitor that suppresses glioblastoma by dual targeting of both syntenin PDZ domains;2024-04-04

3. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis;Molecular Cancer Therapeutics;2023-06-29

4. Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target;Biomedicines;2023-03-27

5. Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma;Cancers;2023-03-16